Prävention gastrointestinaler Tumoren

Der Beitrag fasst den Wissensstand und die Empfehlungen zur Prävention von Ösophagus-, Magen-, Pankreas-, Leberzell-, und kolorektalem Karzinom zusammen mit besonderem Fokus auf die endoskopischen und bildgebenden Vorsorge- und Surveillanceuntersuchungen.

Schlüsselwörter

GI-Tumor - Krebsfrüherkennung - Ösophaguskarzinom - Magenkarzinom - Pankreaskarzinom - Kolonkarzinom - Rektumkarzinom

• Literatur

• 1 Pox CP, Altenhofen L, Brenner H. et al. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 2012; 142: 1460-1467 e1462
• 2 Ferlay J, Soerjomataram I, Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386
• 3 Teufel A, Quante M, Kandulski A. et al. Prävention gastrointestialer Tumore. Z Gastroenterol 2021; 59: 964-982
• 4 Dong J, Thrift AP. Alcohol, smoking and risk of oesophago-gastric cancer. Best Pract Res Clin Gastroenterol 2017; 31: 509-517
• 5 Wei WQ, Abnet CC, Lu N. et al. Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China. Gut 2005; 54: 759-763
• 6 Ojesina AI, Lichtenstein L, Freeman SS. et al. Landscape of genomic alterations in cervical carcinomas. Nature 2014; 506: 371-375
• 7 Taylor PR, Abnet CC, Dawsey SM. Squamous dysplasia-the precursor lesion for esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2013; 22: 540-552
• 8 Arnold M, Soerjomataram I, Ferlay J. et al. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 2015; 64: 381-387
• 9 Waters JK, Reznik SI. Update on management of squamous cell esophageal cancer. Curr Oncol Rep 2022; 24: 375-385
• 10 Shaheen NJ, Richter JE. Barrettʼs oesophagus. Lancet 2009; 373: 850-861
• 11 Weismuller J, Thieme R, Hoffmeister A. et al. Barrett-Screening: Rationale, aktuelle Konzepte und Perspektiven. Z Gastroenterol 2019; 57: 317-326
• 12 Shaheen N, Ransohoff DF. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA 2002; 287: 1972-1981
• 13 Chiba N, De Gara C, Wilkinson J. et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997; 112: 1798-1810
• 14 Bornschein J, Malfertheiner P. Helicobacter pylori and gastric cancer. Digestive Diseases 2014; 32: 249-264
• 15 Wex T, Venerito M, Kreutzer J. et al. Serological prevalence of helicobacter pylori infection in Saxony-Anhalt, Germany, in 2010. Clin Vaccine Immunol 2011; 18: 2109-2112
• 16 Choi IJ, Kim CG, Lee JY. et al. Family history of gastric cancer and helicobacter pylori treatment. N Engl J Med 2020; 382: 427-436
• 17 Moehler M, Al-Batran SE, Andus T. et al. S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009OL. Z Gastroenterol 2019; 57: 1517-1632
• 18 Moehler M, Langer T, Bender T. et al. Leitlinienreport zur S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs – Version 2.0 – August 2019. AWMF-Registernummer: 032/009OL. Z Gastroenterol 2019; 57: e418-e671
• 19 Malfertheiner P, Megraud F, OʼMorain CA. et al. Management of Helicobacter pylori infection–the Maastricht IV/Florence Consensus Report. Gut 2012; 61: 646-664
• 20 Rugge M, Genta RM. Staging gastritis: an international proposal. Gastroenterology 2005; 129: 1807-1808
• 21 Selgrad M, Bornschein J, Kandulski A. et al. Combined gastric and colorectal cancer screening – a new strategy. Int J Mol Sci 2018; 19: 3854
• 22 Stefanini B, Tonnini M, Serio I. et al. Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement. Expert Rev Anticancer Ther 2022; 22: 371-381
• 23 Kusnik A, Hunter N, Rasbach E. et al. Co-medication and nutrition in hepatocellular carcinoma: potentially preventative strategies in hepatocellular carcinoma. Dig Dis 2021; 39: 526-533
• 24 Proneth A, Zeman F, Schlitt HJ. et al. Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis. Ann Surg Oncol 2014; 21: 3096-3107
• 25 Singal A, Volk ML, Waljee A. et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009; 30: 37-47
• 26 Santi V, Trevisani F, Gramenzi A. et al. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. J Hepatol 2010; 53: 291-297
• 27 Vrieling A, Bueno-de-Mesquita HB, Boshuizen HC. et al. Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2010; 126: 2394-2403
• 28 Stolzenberg-Solomon RZ. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 2002; 155: 783-792
• 29 Wang YT, Gou YW, Jin WW. et al. Association between alcohol intake and the risk of pancreatic cancer: a dose-response meta-analysis of cohort studies. BMC Cancer 2016; 16: 212
• 30 Seufferlein T, Porzner M, Becker T. et al. S3-Leitlinie zum exokrinen Pankreaskarzionom. Z Gastroenterol 2013; 51: 1395-1440
• 31 Park Y, Hunter DJ, Spiegelman D. et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 2005; 294: 2849
• 32 Guraya SY. Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review. World J Gastroenterol 2015; 21: 6026-6031
• 33 Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology 2015; 148: 1244-1260.e1216
• 34 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF). S3-Leitlinie Kolorektales Karzinom. AWMF-Registernummer: 021/007OL. 2019. Im Internet (Stand: 15.08.2022): https://www.awmf.org/uploads/tx_szleitlinien/021-007OLl_S3_Kolorektales-Karzinom-KRK_2019-01.pdf
• 35 Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 2012; 13: 518-527
• 36 Bibbins-Domingo K. U.S. Preventive Services Task Force (USPSTF). Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2016; 164: 836
• 37 Brenner H, Chang-Claude J, Jansen L. et al. Reduced risk of colorectal cancer up to 10 years after screening, Surveillance, or diagnostic colonoscopy. Gastroenterology 2014; 146: 709-717